1. Home
  2. CAN vs LAB Comparison

CAN vs LAB Comparison

Compare CAN & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Canaan Inc.

CAN

Canaan Inc.

BUY

Current Price

$0.21

Market Cap

330.0M

Sector

Technology

ML Signal

BUY

Logo Standard BioTools Inc.

LAB

Standard BioTools Inc.

HOLD

Current Price

$0.63

Market Cap

270.6M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAN
LAB
Founded
2013
1999
Country
Singapore
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Laboratory Analytical Instruments
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
330.0M
270.6M
IPO Year
2019
2008

Fundamental Metrics

Financial Performance
Metric
CAN
LAB
Price
$0.21
$0.63
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
★ $1.39
N/A
AVG Volume (30 Days)
★ 5.9M
758.2K
Earning Date
11-17-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 61.54
EPS
N/A
★ 0.26
Revenue
N/A
★ $101,937,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$70.43
N/A
P/E Ratio
★ N/A
$2.49
Revenue Growth
★ N/A
N/A
52 Week Low
$0.15
$0.62
52 Week High
$1.95
$1.72

Technical Indicators

Market Signals
Indicator
CAN
LAB
Relative Strength Index (RSI) 27.19 38.27
Support Level $0.15 $0.63
Resistance Level $0.56 $0.79
Average True Range (ATR) 0.02 0.05
MACD -0.01 -0.01
Stochastic Oscillator 0.07 5.56

Price Performance

Historical Comparison
CAN
LAB

About CAN Canaan Inc.

Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment and the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts and accessories. Geographically, the company derives its maximum revenue from United States.

About LAB Standard BioTools Inc.

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. The company operates in one segment. Its technology includes: Genomics; Single-cell proteomics; Spatial proteomics. Its platforms include: Biomark X9 System, CyTOF XT system, and Hyperion XTi Imaging System. The company offers a diverse range of instrumentation, consumables, and services that generate high-quality data across early discovery, translational and clinical research. Geographically, it operates in Americas; EMEA and Asia-Pacific.

Share on Social Networks: